STIMNeuronetics, Inc.

STIM Stock Price, Valuation & Chart | Neuronetics, Inc.

Compare

$1.890-0.07 (-3.33%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research

Overview Financials Dividends Ratios

STIM Historical price chart

STIM Key Stats

Market Capitalization143.63M

PE Ratio-4.28

EPS-0.44

Trading Volume967.69K

Today's High/Low1.95/1.85

Dividend Yield0.00

52 Week High/Low3.44/0.8

Shares Outstanding76.20M

STIM Financial Statement

STIM Analyst ratings

STIM Analysis & performance metrics

STIM Company profile

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and…

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy…

STIM Management team

Name

Position

Keith J. SullivanCEO

President, Chief Executive Officer & Director

W. Andrew Macan J.D.

EVice President, Chief Legal Officer & Corporate Secretary

Steven E. Pfanstiel C.M.A., M.B.A.CFO

Executive Vice President, Treasurer & Chief Financial Officer

Jeffrey S. Jones

Senior Vice President & Chief of Operations

Cory S. AndersonCTO

SVice President & Chief Technology Officer

Lisa Metzner-Rosas

Senior Vice President & Chief Marketing Officer

Sara Grubbs

Senior Vice President & Chief Revenue Officer

William P. Leonard

Chief Clinic Officer

Name

Position

Keith J. SullivanCEO

President, Chief Executive Officer & Director

W. Andrew Macan J.D.

EVice President, Chief Legal Officer & Corporate Secretary

Steven E. Pfanstiel C.M.A., M.B.A.CFO

Executive Vice President, Treasurer & Chief Financial Officer

Jeffrey S. Jones

Senior Vice President & Chief of Operations

Cory S. AndersonCTO

SVice President & Chief Technology Officer

Lisa Metzner-Rosas

Senior Vice President & Chief Marketing Officer

Sara Grubbs

Senior Vice President & Chief Revenue Officer

William P. Leonard

Chief Clinic Officer

Management Team

Keith J. SullivanCEO

President, Chief Executive Officer & Director

W. Andrew Macan J.D.

EVice President, Chief Legal Officer & Corporate Secretary

Steven E. Pfanstiel C.M.A., M.B.A.CFO

Executive Vice President, Treasurer & Chief Financial Officer

Jeffrey S. Jones

Senior Vice President & Chief of Operations

Cory S. AndersonCTO

SVice President & Chief Technology Officer

Lisa Metzner-Rosas

Senior Vice President & Chief Marketing Officer

Sara Grubbs

Senior Vice President & Chief Revenue Officer

William P. Leonard

Chief Clinic Officer

Management

Keith J. SullivanCEO

President, Chief Executive Officer & Director

W. Andrew Macan J.D.

EVice President, Chief Legal Officer & Corporate Secretary

Steven E. Pfanstiel C.M.A., M.B.A.CFO

Executive Vice President, Treasurer & Chief Financial Officer

Jeffrey S. Jones

Senior Vice President & Chief of Operations

Cory S. AndersonCTO

SVice President & Chief Technology Officer

Lisa Metzner-Rosas

Senior Vice President & Chief Marketing Officer

Sara Grubbs

Senior Vice President & Chief Revenue Officer

William P. Leonard

Chief Clinic Officer

Total 8 executives

STIM Frequently asked questions

What is Neuronetics, Inc. (STIM) Stock Price?

Current stock price of Neuronetics, Inc. (STIM) stock is $1.890. The stock price is -3.33% lower in the session. The intraday range can be seen from this page. Volume of Neuronetics, Inc. (STIM) stock is 967.69K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Neuronetics, Inc. (STIM) stock price going up or down today?

The stock price of Neuronetics, Inc. (STIM) can change with earnings, company news, and overall market sentiment. Neuronetics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Neuronetics, Inc. stock expensive at its current price?

Whether Neuronetics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for STIM on this page is -4.28. EPS on this page is -0.44. Compare those figures with peers and growth expectations before deciding if the current Neuronetics, Inc. price is justified.

How has the stock price of Neuronetics, Inc. (STIM) performed historically?

Historical performance for Neuronetics, Inc. (STIM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how STIM reacted to past earnings and market events.

Should I buy Neuronetics, Inc. (STIM) stock, at this price?

Buying Neuronetics, Inc. (STIM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.